AACR visits Washington DC
On January 8, 2016, fifteen distinguished American Association for Cancer Research (AACR) leadership and members including Dr. Arul Chinnaiyan, from 10
cancer centers and medical institutions all across the U.S. (from nine
different states) participated in meetings with top officials from the Food and Drug Administration (FDA) to discuss FDA’s current thinking on how the agency might regulate NGS-based tests, as well as interrelated topics, such as laboratory developed tests (LDTs) and companion diagnostics for cancer therapies. The
AACR used the meeting as an opportunity to provide information and
important perspectives to the FDA as it begins developing NGS-related
guidance for the scientific community.
In addition, the AACR team was invited to a separate meeting with senior
staffers for Vice President Joe Biden to discuss ways the Vice
President can further his commitment to cancer research. The Vice President
believes that his power is in: 1) serving as a convener; 2)
influencing Federal agencies; and 3) spurring public-private
partnerships; he is specifically interested in determining how to incentivize collaboration and breaking down barriers.
The AACR Team was well-received by both the FDA officials as well as the Vice President's staff, the meetings were productive and encouraging.